Aurgalys Team
Selected Customers
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]

.:: Biocorp Production [ALCOR] ::.

Founded by Jacques Gardette in 2004, Biocorp has since built a strong experience in the development, production and marketing of medical devices for the pharmaceutical industry. The company developed innovative solutions for drug packaging and secured syringes. Biocorp signed two contracts for these products with Japanese Nipro and Italian Ompi, that could bring almost €20M in revenues by 2018. The company has also dedicated a significant portion of its R&D effort in the development of connected medical devices. The most advanced product is the Datapen (insulin pen) which is an injection device connected to a mobile application, allowing the user to record the dose of insulin injected, as well as the blood glucose level. The Datapen was developed to improve diabetic patients’ adherence to their treatment.

The coverage was initiated Sept 9th, 2015

Our target price for Biocorp as of Jan 31st, 2017, is €17.00/ share